Braze, Inc. - Class A Common Stock (NQ:BRZE)
Price and Volume
Detailed Quote| Volume | 2,731,597 |
| Open | 29.78 |
| Bid (Size) | 30.30 (700) |
| Ask (Size) | 30.35 (300) |
| Prev. Close | 29.87 |
| Today's Range | 29.70 - 31.20 |
| 52wk Range | 23.91 - 48.33 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What Analysts Are Saying About Braze Stock ↗
October 22, 2025
Braze To Report Fiscal Third Quarter 2026 Results
November 18, 2025
Braze (BRZE): Buy, Sell, or Hold Post Q2 Earnings?
November 06, 2025
3 Software Stocks Worth Your Attention
November 02, 2025
1 Russell 2000 Stock with Exciting Potential and 2 We Turn Down
October 30, 2025
1 Cash-Heavy Stock with Promising Prospects and 2 We Ignore
October 21, 2025
Why Braze (BRZE) Stock Is Falling Today
October 10, 2025
Why These 3 Tech Stocks Deserve Your Attention in Q4 ↗
October 03, 2025
1 Growth Stock to Stash and 2 Facing Headwinds
September 29, 2025
Why Braze Stock Beat the Market Today ↗
September 17, 2025
Frequently Asked Questions
Is Braze, Inc. - Class A Common Stock publicly traded?
Yes, Braze, Inc. - Class A Common Stock is publicly traded.
What exchange does Braze, Inc. - Class A Common Stock trade on?
Braze, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Braze, Inc. - Class A Common Stock?
The ticker symbol for Braze, Inc. - Class A Common Stock is BRZE on the Nasdaq Stock Market
What is the current price of Braze, Inc. - Class A Common Stock?
The current price of Braze, Inc. - Class A Common Stock is 30.30
When was Braze, Inc. - Class A Common Stock last traded?
The last trade of Braze, Inc. - Class A Common Stock was at 12/05/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.